These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20275115)

  • 1. The effect of 2,3-dimercaptopropanol (BAL) on the whole blood and plasma concentration of arsenic after mapharsen in cats.
    RIKER WF; ROSENFELD G
    J Pharmacol Exp Ther; 1946 Aug; 87(4 Suppl):72-5. PubMed ID: 20275115
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical uses of 2,2-dimercaptopropanol (BAL); the systemic treatment of experimental arsenic poisoning (mapharsen, lewisite, phenyl arsenoxide) with BAL.
    EAGLE H; MAGNUSON HJ; FLEISCHMAN R
    J Clin Invest; 1946 Jul; 25(4):451-66. PubMed ID: 21001620
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical uses of 2,3-dimercaptopropanol (BAL); the effect of BAL on the excretion of arsenic in arsenical intoxication.
    LUETSCHER JA; EAGLE H; LONG-COPE WT
    J Clin Invest; 1946 Jul; 25(4):534-40. PubMed ID: 21001627
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical uses of 2,3-dimercaptopropanol (BAL); the treatment of arsenical dermatitis with preparations of BAL.
    LONGCOPE WT; LUETSCHER JA
    J Clin Invest; 1946 Jul; 25(4):528-33. PubMed ID: 21001626
    [No Abstract]   [Full Text] [Related]  

  • 5. Poisoning from inhalation of the vapors of lewisite and phenyldichlorarsine; its pathology in the dog and treatment with 2,3-dimercaptopropanol (BAL).
    HARRISON HE; ORDWAY NK
    J Pharmacol Exp Ther; 1946 Aug; 87(4 Suppl):76-80. PubMed ID: 20275116
    [No Abstract]   [Full Text] [Related]  

  • 6. The treatment by 2,3-dimercaptopropanol (BAL) of the systemic toxic effects of skin contamination with lewisite and phenyldichlorarsine.
    HARRISON HE; DURLACHER SH
    J Pharmacol Exp Ther; 1946 Aug; 87(4 Suppl):81-4. PubMed ID: 20275117
    [No Abstract]   [Full Text] [Related]  

  • 7. The treatment of acute gold and arsenic poisoning; use of BAL (2,3-dimercaptopropanol, British anti-lewisite).
    COHEN A; GOLDMAN J; DUBBS AW
    J Am Med Assoc; 1947 Mar; 133(11):749-52. PubMed ID: 20283984
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical uses of 2,3-dimercaptopropanol (BAL); the treatment of complications of arseno-therapy with BAL (British anti-lewisite).
    CARLETON AB; PETERS RA
    J Clin Invest; 1946 Jul; 25(4):497-527. PubMed ID: 21001625
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical uses of 2,3-dimercaptopropanol (BAL); the treatment of lewisite burns of the eye with BAL.
    HUGHES WF
    J Clin Invest; 1946 Jul; 25(4):541-8. PubMed ID: 21001628
    [No Abstract]   [Full Text] [Related]  

  • 10. BAL in the treatment of massive overdosage with mapharsen.
    ARMSTRONG CD; FLEMING WJ; THALMANN WG
    Calif Med; 1948 Oct; 69(4):247-52. PubMed ID: 18884800
    [No Abstract]   [Full Text] [Related]  

  • 11. Suppression of treponemicidal action of arsenic with 2,3-dimercaptopropanol (BAL) report of clinical observations in five cases.
    De OREO GA
    Arch Derm Syphilol; 1947 Nov; 56(5):695-8. PubMed ID: 20272216
    [No Abstract]   [Full Text] [Related]  

  • 12. The systemic treatment of arsenic poisoning with BAL (2,3-dimercaptopropanol).
    EAGLE H
    J Vener Dis Inf; 1946 May; 27():114-21. PubMed ID: 21028660
    [No Abstract]   [Full Text] [Related]  

  • 13. An explosive reaction following the simultaneous administration of sodium arsenite and dithioglycerol (BAL) in vivo.
    KOPPANYI T; SPERLING F
    Anat Rec; 1946 Dec; 96(4):501. PubMed ID: 20341381
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of BAL in the treatment of arsenical neuropathy.
    MALHOTRA SL
    Ind Med Gaz; 1951 Aug; 86(8):340-3. PubMed ID: 14888288
    [No Abstract]   [Full Text] [Related]  

  • 15. Time relationships in the reversal by BAL of the chemotherapeutic effect of mapharsen.
    PFEIFFER CC; JENNEY EH; ROSS CA
    Fed Proc; 1947; 6(1):363. PubMed ID: 20249608
    [No Abstract]   [Full Text] [Related]  

  • 16. Condensation of 2,3-dimercaptopropanol with oxophenarsine hydrochloride; toxicity and chemotherapeutic effect.
    SAWYERS JL; BURROWS B; MAREN TH
    Proc Soc Exp Biol Med; 1949 Feb; 70(2):194-7. PubMed ID: 18112762
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical uses of 2,3-dimercaptropropanol (BAL); the effect of BAL on the excretion of arsenic in normal subjects and after minimal exposure to arsenical smoke.
    WEXLER J; EAGLE H
    J Clin Invest; 1946 Jul; 25(4):467-73. PubMed ID: 21001621
    [No Abstract]   [Full Text] [Related]  

  • 18. British anti-lewisite; antidotal effects against therapeutic arsenicals.
    STOCKEN LA; THOMPSON RH; WHITTAKER VP
    Biochem J; 1947; 41(1):47-52. PubMed ID: 20287850
    [No Abstract]   [Full Text] [Related]  

  • 19. [BAL, a new remedy for the treatment of poisoning from arsenic and other heavy metals].
    FERRARI AV
    Minerva Med; 1947 Jan; 38(1):16. PubMed ID: 18920182
    [No Abstract]   [Full Text] [Related]  

  • 20. Reactions to twenty-day intensive therapy with mapharsen and bismuth for syphilis with a note on the use of BAL in their management.
    CORMIA FE; BLAUNER SG
    Am J Syph Gonorrhea Vener Dis; 1947 Mar; 31(2):135-49. PubMed ID: 20289293
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.